Greenhouse Funds Lllp Catalent, Inc. Transaction History

Greenhouse Funds Lllp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $3.35 Million - $5.48 Million	73,785 Added 15.2%	559,069 $36.7 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $19.9 Million - $38.9 Million	480,768 Added 10645.88%	485,284 $21.8 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $326,777 - $510,759	4,516 New	4,516 $327,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Greenhouse Funds Lllp, based on Form 13F filings with the SEC.

Stay updated on Greenhouse Funds Lllp with notifications on news.